| |
|
|
|
Evelo Biosciences Inc.  
|
|
6.39 0.28 (0.05%) |
08-19 16:00 |
|
Open: |
6.2 |
Pre close: |
6.11 |
Target:
|
8.59
|
|
High: |
6.558 |
Low: |
6.1707 |
Resistance:
|
7.36
8.88
|
|
Volume: |
10,586 |
Market Cap: |
205M |
Support:
|
4.90
4.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.01
 |
MACD |
MACD(12,26):
|
-0.42 |
|
MA(20): |
6.27  |
Signal(12,26,9): |
-0.49 |
|
MA(100): |
7.71 |
Stochastic Oscillator |
%K(14,3):
|
51.37 |
|
MA(250): |
9.43 |
%D(3): |
42.25 |
|
Average Volume(K) |
3-Month: |
4202
|
52-Week |
High:
|
15.89 |
|
10-Days: |
6533 |
Low: |
4.90 |
|
RSI |
RSI(14):
|
47.77 |
Change(%): |
-50.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.270 |
Return on Equity (ttm) |
-54.7 |
Shares Out. (M) |
32.04 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-29.7 |
Shares Float (M) |
11.80 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.68 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
85.20 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1590 |
|
Book Value (p.s.) |
3.120 |
EBITDA (p.s.) |
-2.283 |
P/E |
-2.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-61.47 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-42.52 |
P/CF |
-3.33 |
|
|
|
|
|
|
